Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
LTR Retrotransposons03:08

LTR Retrotransposons

LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signs of Cross-Reactivity Between SARS-CoV-2 and Other Coronaviruses in a Pre-Vaccine Swedish School Setting.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals.

PLOS global public health·2025
Same author

Logistics for Rapid Isolation of Viruses From Humans.

Health security·2024
Same author

High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022.

Emerging infectious diseases·2023
Same author

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells.

Cancers·2023
Same author

Rapid emergence of omicron sublineages expressing spike protein R346T.

The Lancet regional health. Europe·2022

Related Experiment Video

Updated: May 12, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicity.

David Hallengärd1, Britta Wahren, Andreas Bråve

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. david.hallengard@ki.se

Viral Immunology
|April 12, 2013
PubMed
Summary

This study optimized the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) for DNA vaccines. Truncated RT enhanced immune responses, showing potential for improved HIV-1 vaccine development.

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • The human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a key target for antiretroviral therapy.
  • HIV-1 RT also holds potential as a vaccine antigen for inducing immune responses.
  • Enhancing the immunogenicity of vaccine antigens is crucial for effective vaccine design.

Purpose of the Study:

  • To investigate the immunogenicity of plasmid-encoded truncated HIV-1 RT.
  • To compare the cell-mediated immune responses induced by truncated RT versus full-length RT.
  • To evaluate the efficacy of truncated RT as part of a multigene HIV-1 DNA vaccine.

Main Methods:

  • Constructing and expressing truncated and full-length HIV-1 RT plasmids.
  • Comparing in vitro expression levels of different RT constructs.
  • Assessing cell-mediated immune responses in BALB/c and HLA-A0201 transgenic mice.
  • Evaluating truncated RT within a multigene HIV-1 vaccine construct.

Main Results:

  • Truncated HIV-1 RT demonstrated enhanced in vitro expression compared to full-length RT.
  • The truncated RT induced significantly stronger cell-mediated immune responses in mice.
  • These enhanced immune responses were maintained when truncated RT was part of a multigene vaccine.
  • Linking RT to HIV-1 protease did not further boost RT immunogenicity.

Conclusions:

  • Deleting non-immunogenic regions effectively enhances the immunogenicity of HIV-1 RT for DNA vaccines.
  • Truncated HIV-1 RT is a promising candidate antigen for developing more effective HIV-1 vaccines.
  • This optimization strategy can be applied to other DNA vaccine constructs encoding RT or similar antigens.